The Brinkley Center and Kompassion are urging Congress to advance “energetic medicine” as an equal, non-drug parallel to a currently moving $50 million psychedelics initiative. The article provides a policy advocacy update rather than concrete regulatory or funding outcomes, implying limited immediate market impact.
The Brinkley Center and Kompassion are urging Congress to advance “energetic medicine” as an equal, non-drug parallel to a currently moving $50 million psychedelics initiative. The article provides a policy advocacy update rather than concrete regulatory or funding outcomes, implying limited immediate market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.00
